Mylan increases Abbott's ownership stake in pending deal

Mylan Inc. said it expects its controversial $5.3 billion deal to acquire Abbott Laboratories' generic European operations and merge, creating a new holding company in the tax-friendlier Netherlands, to close in first quarter 2015...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.